Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse (NCT01545505) | Clinical Trial Compass
CompletedNot Applicable
Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse
France6 participantsStarted 2012-10
Plain-language summary
Relapse of post-traumatic stress disorder (PTSD) remains challenging. In addition, factors predicting PTSD relapse are still unknown. The aim of this study is to examine whether clinical and neuropsychological changes (e.g., attentional bias toward aversive cues) that characterized PTSD can be observed in people with past PTSD (children and their families) and whether these persistent changes are predictive of PTSD relapse.
Who can participate
Age range
9 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
For children
Inclusion Criteria:
* Children (9/18 years)
* Patients who have lived a traumatic event (physical assault and road accident) and who have a PTSD.
* French speaker.
* Participants must sign the informed consent and they must be affiliated to the social insurance.
Exclusion Criteria
* Children who have a neurological pathology.
* Children who have brain damage or brain-injured
* Subject having participated in a biomedical research in three months preceding the inclusion
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial was studying 'attentional scores' as a possible marker for PTSD relapse — can you help me understand what that means, and whether tracking attention or concentration is something that could be relevant to monitoring my own condition?
2Since this trial is already completed, have the results been published anywhere, and if so, what did they find about predicting PTSD relapse that might be useful for my treatment plan?
3This study was focused on identifying markers of relapse rather than testing a treatment — does that mean it was mainly observational, and what kinds of things were participants actually asked to do?
4Given that researchers were looking for biological or psychological signals that predict PTSD relapse, are there any tests or assessments my care team already uses to watch for signs that my symptoms might worsen over time?
5Are there currently any active trials or evidence-based treatments you would recommend I look into alongside this kind of research, especially if my main concern is preventing a relapse of PTSD?'
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Attentional score
Timeframe: baseline at the first visit (T0), at 6 months, at 9 months